Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation

Clinical trial NCT03483324 · COMPLETED

Trial details

NCT number: NCT03483324
Sponsor: Angiocrine Bioscience
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia in Remission Myelodysplastic Syndromes Other Acute Leukemias

Start date: 2018-04-24
Primary completion: 2020-12-21
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.